Beta Bionics, Inc. Common Stock (BBNX) Q4 2024 Annual Earnings
BBNX·Reported March 25, 2025·After market close
Beta Bionics, Inc. Common Stock reported Q4 2024 revenue of $20.4M, beat analyst consensus of $16.1M by $4.3M. Diluted EPS came in at $-1.82, missed the $-0.42 consensus by $1.40.
Revenue
$20.4Mbeat by $4.3M
Consensus: $16.1MDiluted EPS
$-1.82missed by $1.40
Consensus: $-0.42
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Beta Bionics, Inc. Common Stock's Q4 2024 earnings report.
Beta Bionics, Inc. Common Stock (BBNX) reported Q4 2024 earnings on March 25, 2025 after market close.
Beta Bionics, Inc. Common Stock reported revenue of $20.4M and diluted EPS of $-1.82 for Q4 2024.
Revenue beat the consensus estimate of $16.1M by $4.3M. EPS missed the consensus estimate of $-0.42 by $1.40.
You can read the 10-K periodic report (0000950170-25-044516) directly on SEC EDGAR. The filing index links above go to sec.gov.